Search

everythinglearnresearchcommunity

for

Search:↓

Urologists should monitor mental health in patients taking finasteride due to potential links to suicidal thoughts, adjusting dosage or stopping use if necessary. More research is needed to confirm if finasteride causes these thoughts.

Partial hair-sparing brain radiotherapy is possible and doesn't affect cancer control but still causes noticeable hair loss.

Testosterone pellets may help women's sexual function but have safety concerns and need more research.

No single treatment is clearly effective for central serous chorioretinopathy.

New skin repair methods show promise but need to be safer and more accessible.

Platelet-rich plasma treatment is more effective than pelvic floor muscle training for improving quality of life in women with stress urinary incontinence.

Most trichological shampoo ingredients lack strong evidence for effectiveness against hair loss.

New understanding and treatments for hair loss are improving, but more research is needed.

PRP and PRF show promise for hair growth but need more research for consistent and safe use.

Nanoparticles can effectively treat diseases by modifying blood vessel growth.

The document concludes that personalized hormonal treatments are important for transgender individuals and more research is needed for non-binary treatments.

MK-2206 was safe and effectively blocked AKT signaling in cancer patients, warranting more trials.

Persistent radiation-induced hair loss is dose-dependent, and treatments like topical minoxidil can be effective.

Sacituzumab govitecan improves quality of life and symptoms in breast cancer patients, except for causing more diarrhea.

Higher doses of the medication valproate can cause hair loss, which may stop when the dose is lowered or the medication is stopped.

The Hair Check tool can measure hair loss, but patients' own reports are more reliable for assessing hair loss during chemotherapy.

Palbociclib generally maintains or improves quality of life in advanced breast cancer patients.

Certain cancer drugs can cause skin issues like rashes and itching.

Advanced hydrogels can autonomously deliver drugs to treat radiation skin injuries, but challenges remain for clinical use.

Auranofin shows promise as a cancer treatment, especially when combined with other therapies.

Cancer treatments can cause hair loss, but it is often reversible and can be managed with scalp cooling and support.

Topical sensitizers have mixed success in treating alopecia areata.

Effective vaccines and treatments are crucial for long-term COVID-19 control.

Cold Plasma shows promise for healing wounds by killing bacteria and helping tissue grow.

The updated GRADE guidance advises considering context when interpreting variability in research results and introduces tools for assessing subgroup effects.

The guideline provides healthcare professionals in South Africa with instructions for comprehensive, multidisciplinary gender-affirming care, including HIV prevention and treatment for transgender and gender diverse individuals.

Herbal remedies may help with hair loss but need more research.

Autologous platelet concentrates show promise in esthetic treatments but need more standardized research.

The 2015 Hair Research Congress concluded that stem cells, maraviroc, and simvastatin could potentially treat Alopecia Areata, topical minoxidil, finasteride, and steroids could treat Frontal Fibrosing Alopecia, and PTGDR2 antagonists could also treat alopecia. They also found that low-level light therapy could help with hair loss, a robotic device could assist in hair extraction, and nutrition could aid hair growth. They suggested that Alopecia Areata is an inflammatory disorder, not a single disease, indicating a need for personalized treatments.

Breast implants are generally safe, but textured implants may rarely cause lymphoma.